Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Adam Esbenshade

5 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    VICCPED1258

    09/06/2012

    Mutations in DICER1 and Related MicroRNA Processing Genes in Dysplasias, Dysontogenic Diseases, Tumors and Other Conditions

    Health Services Research

    VICCPED14127

    01/08/2015

    Infectious Disease Outcomes in Pediatric Oncology Patients

    Other

    COGACNS02B3

    02/04/2013

    ACNS02B3 - A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens

    Supportive Care

    COGACCL1333

    04/28/2016

    A Phase III Randomized, Open Label, Multi-center Study on the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B cell) Treated with Pegylated (PEG) L-Asparaginase

    Supportive Care

    COGACCL0933

    11/16/2011

    A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)


    Print this page for your doctor